Become a Member

In vitro diagnostics (IVDs) test a sample of tissue or bodily fluid in an effort to diagnose a disease or condition. Effectively used, IVDs help to reduce hospital stays, support patients to look after their own health and release resources for use elsewhere in the NHS, resulting in a healthier population and stronger economic growth.

BREXIT Contingency Planning Enquiries
 

BIVDA would like to help any members who seek clarification on the likely impact of a no-deal Brexit on the shipment of medical goods. However, the volatility and uncertainty of the situation makes it impossible for us to give any definitive information. We have been involved in meetings and discussions with the DHSC MDCC EU Exit Contingency Team and they have given us a contact address as below:
 

Where can I find more information and ask questions?

For any further queries, please do not hesitate to contact us via email at mdcc-contingencyplanning@dhsc.gov.uk. Information about EU Exit can also be accessed via the gov.uk website: https://www.gov.uk/government/publications/medical-devices-and-clinical-consumables-no-deal-brexit-preparation-plans-update​

 
The IVD Industry

Industry

Find out more about how BIVDA represents the IVD industry on behalf of its members. You can also access our Events Diary and Members’ Area. If you are not already a member, discover how you can ‘join us’!

Read More
Healthcare Professionals
 

Healthcare Professionals

If you are a healthcare professional, please click here to find out more about the value of IVDs and how they can deliver improved outcomes for patients and the NHS.

Read More
The Value of IVDs
 

The Value of IVDs

Ever wondered what an IVD is? Want to know more about how diagnostics are helping patients? Keen to discover more about the role of the industry? You can find out the answer to all of these questions and more, here.

Read More
Latest blog post
 

Latest Blog

How can we break through the innovation adoption barrier in the UK, make a more efficient use of NHS resources and improve patient care?
In a speech to the All Party Parliamentary Group for Life Sciences, BIVDA’s Chairman, Darren Stenlake, called for partnership and a framework that drives and fosters innovation adoption to successfully capitalise on opportunities ahead.

Read More
 
Latest blog post
 

Latest Report

Near Patient Testing - The Value Story - The report highlights the value of near patient testing in the delivery of care to patients, allowing timely diagnosis at the bedside, in general practice, or in the community, and provides insight into the major role it can play in redesigning services around the needs of the patient.              Download Here

Event Diary
 

BIVDA meeting dates

14 June - Regulatory Affairs Working Party

20 June - Procurement Working Party

18 July – Near Patient Testing Group

3 October – Autumn General Meeting

15-16 October – Regulatory Affairs Working Party Seminar (Manchester)

 

 

 

More Events